Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report
Abstract Paraneoplastic coagulopathies are uncommon in patients with lymphoma. We report the first case of an acquired coagulopathy in a patient with isolated primary central nervous system lymphoma (PCNSL) demonstrating large‐cell histology. In our patient, a paraneoplastic factor VII inhibitor sig...
Main Authors: | Vanshika Goyal, Giselle Salmasi, Andrew D. Leavitt, James L. Rubenstein, Rahul Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.482 |
Similar Items
-
Neurosurgical Management of Central Nervous System Lymphoma: Lessons Learnt from a Neuro-Oncology Multidisciplinary Team Approach
by: Maria Alexandra Velicu, et al.
Published: (2023-04-01) -
Central Nervous System Burkitt Lymphoma in a child (A case report).
by: Hassan Mahmoodi Nesheli
Published: (2015-09-01) -
Fractionated Stereotactic Radiation for Central Nervous System Lymphoma: Retrospective Analysis of Initial Cases
by: Daniel G. Schep, et al.
Published: (2023-09-01) -
Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
by: Marion Alcantara, et al.
Published: (2021-10-01) -
Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy
by: Isabel Cornell, et al.
Published: (2023-07-01)